HEADER COMPLEMENT REGULATORY PROTEIN 01-JUN-94 1CDS TITLE STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN COMPLEMENT TITLE 2 REGULATORY PROTEIN CD59 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CD59; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS COMPLEMENT REGULATORY PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR C.M.FLETCHER,R.A.HARRISON,P.J.LACHMANN,D.NEUHAUS REVDAT 6 23-OCT-24 1CDS 1 HETSYN REVDAT 5 29-JUL-20 1CDS 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 13-JUL-11 1CDS 1 VERSN REVDAT 3 25-AUG-09 1CDS 1 SOURCE REVDAT 2 24-FEB-09 1CDS 1 VERSN REVDAT 1 30-SEP-94 1CDS 0 JRNL AUTH C.M.FLETCHER,R.A.HARRISON,P.J.LACHMANN,D.NEUHAUS JRNL TITL STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN JRNL TITL 2 COMPLEMENT REGULATORY PROTEIN CD59. JRNL REF STRUCTURE V. 2 185 1994 JRNL REFN ISSN 0969-2126 JRNL PMID 7520819 JRNL DOI 10.1016/S0969-2126(00)00020-4 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.M.FLETCHER,R.A.HARRISON,P.J.LACHMANN,D.NEUHAUS REMARK 1 TITL SEQUENCE-SPECIFIC 1H-NMR ASSIGNMENTS AND FOLDING TOPOLOGY OF REMARK 1 TITL 2 HUMAN CD59 REMARK 1 REF PROTEIN SCI. V. 2 2015 1993 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.DAVIES,P.J.LACHMANN REMARK 1 TITL MEMBRANE DEFENCE AGAINST COMPLEMENT LYSIS: THE STRUCTURE AND REMARK 1 TITL 2 BIOLOGICAL PROPERTIES OF CD59 REMARK 1 REF IMMUNOL.RES. V. 12 258 1993 REMARK 1 REFN ISSN 0257-277X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CDS COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172264. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 11 47.60 -106.62 REMARK 500 1 ASP A 12 30.30 -164.46 REMARK 500 1 VAL A 17 141.81 -171.50 REMARK 500 1 CYS A 19 41.01 -100.70 REMARK 500 1 SER A 20 -168.14 47.10 REMARK 500 1 ASP A 22 36.72 74.06 REMARK 500 1 PHE A 47 44.51 -86.01 REMARK 500 1 ASN A 48 -37.09 -166.14 REMARK 500 1 GLU A 56 -165.03 -125.49 REMARK 500 1 ASN A 57 -60.64 -151.34 REMARK 500 1 LEU A 59 172.36 175.90 REMARK 500 1 TYR A 61 122.26 179.60 REMARK 500 1 ASN A 72 71.21 56.00 REMARK 500 1 GLU A 73 60.48 163.47 REMARK 500 1 GLN A 74 -58.13 -137.76 REMARK 500 1 GLU A 76 177.50 76.69 REMARK 500 2 ASP A 12 42.19 -176.62 REMARK 500 2 ALA A 16 92.95 41.22 REMARK 500 2 CYS A 19 101.63 -48.64 REMARK 500 2 SER A 20 77.30 -119.97 REMARK 500 2 SER A 21 77.49 172.27 REMARK 500 2 ASP A 24 15.35 -148.30 REMARK 500 2 ASN A 46 36.88 -144.48 REMARK 500 2 ASN A 48 -45.62 -157.85 REMARK 500 2 GLU A 56 -158.72 -123.91 REMARK 500 2 ASN A 57 -50.64 -157.39 REMARK 500 2 LEU A 59 136.43 -171.36 REMARK 500 2 LEU A 68 61.60 70.26 REMARK 500 2 ASN A 70 46.67 -92.90 REMARK 500 2 PHE A 71 38.93 -89.34 REMARK 500 2 GLU A 73 40.28 165.05 REMARK 500 2 GLN A 74 51.97 -145.84 REMARK 500 2 LEU A 75 -51.63 -145.28 REMARK 500 2 GLU A 76 88.39 64.59 REMARK 500 3 ASP A 12 35.59 171.35 REMARK 500 3 SER A 20 178.76 -57.82 REMARK 500 3 PHE A 23 99.88 -160.67 REMARK 500 3 ILE A 28 79.56 -115.50 REMARK 500 3 ALA A 31 -169.93 -62.48 REMARK 500 3 ASN A 48 -34.92 -177.92 REMARK 500 3 ASN A 57 26.61 -165.04 REMARK 500 3 GLU A 58 82.12 -177.26 REMARK 500 3 THR A 60 79.78 -110.92 REMARK 500 3 LYS A 65 40.96 -143.76 REMARK 500 3 GLU A 73 49.57 -179.74 REMARK 500 3 GLN A 74 26.42 -149.44 REMARK 500 4 ASP A 12 39.90 -165.06 REMARK 500 4 LYS A 14 47.58 -144.84 REMARK 500 4 THR A 15 71.67 -105.13 REMARK 500 4 SER A 20 -177.67 -66.52 REMARK 500 REMARK 500 THIS ENTRY HAS 156 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG A 53 0.20 SIDE CHAIN REMARK 500 1 ARG A 55 0.31 SIDE CHAIN REMARK 500 2 ARG A 53 0.32 SIDE CHAIN REMARK 500 2 ARG A 55 0.30 SIDE CHAIN REMARK 500 3 ARG A 53 0.21 SIDE CHAIN REMARK 500 3 ARG A 55 0.28 SIDE CHAIN REMARK 500 4 ARG A 53 0.15 SIDE CHAIN REMARK 500 4 ARG A 55 0.28 SIDE CHAIN REMARK 500 5 ARG A 53 0.31 SIDE CHAIN REMARK 500 5 ARG A 55 0.30 SIDE CHAIN REMARK 500 6 ARG A 53 0.29 SIDE CHAIN REMARK 500 6 ARG A 55 0.32 SIDE CHAIN REMARK 500 7 ARG A 53 0.28 SIDE CHAIN REMARK 500 7 ARG A 55 0.20 SIDE CHAIN REMARK 500 8 ARG A 53 0.26 SIDE CHAIN REMARK 500 8 ARG A 55 0.23 SIDE CHAIN REMARK 500 9 ARG A 53 0.21 SIDE CHAIN REMARK 500 9 ARG A 55 0.20 SIDE CHAIN REMARK 500 10 ARG A 53 0.21 SIDE CHAIN REMARK 500 10 ARG A 55 0.23 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 1CDS A 1 77 UNP P13987 CD59_HUMAN 26 102 SEQRES 1 A 77 LEU GLN CYS TYR ASN CYS PRO ASN PRO THR ALA ASP CYS SEQRES 2 A 77 LYS THR ALA VAL ASN CYS SER SER ASP PHE ASP ALA CYS SEQRES 3 A 77 LEU ILE THR LYS ALA GLY LEU GLN VAL TYR ASN LYS CYS SEQRES 4 A 77 TRP LYS PHE GLU HIS CYS ASN PHE ASN ASP VAL THR THR SEQRES 5 A 77 ARG LEU ARG GLU ASN GLU LEU THR TYR TYR CYS CYS LYS SEQRES 6 A 77 LYS ASP LEU CYS ASN PHE ASN GLU GLN LEU GLU ASN MODRES 1CDS ASN A 18 ASN GLYCOSYLATION SITE HET NAG B 1 27 HET NAG B 2 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) HELIX 1 H1 PHE A 47 GLU A 56 1IRREGULAR H-BONDS AT C-T END 10 SHEET 1 S1 2 LEU A 1 CYS A 6 0 SHEET 2 S1 2 THR A 15 CYS A 19 -1 O VAL A 17 N CYS A 3 SHEET 1 S2 3 GLN A 34 TRP A 40 0 SHEET 2 S2 3 ALA A 25 ALA A 31 -1 N ALA A 25 O TRP A 40 SHEET 3 S2 3 LEU A 59 LYS A 65 -1 N CYS A 64 O CYS A 26 SSBOND 1 CYS A 3 CYS A 26 1555 1555 2.02 SSBOND 2 CYS A 6 CYS A 13 1555 1555 2.02 SSBOND 3 CYS A 19 CYS A 39 1555 1555 2.02 SSBOND 4 CYS A 45 CYS A 63 1555 1555 2.02 SSBOND 5 CYS A 64 CYS A 69 1555 1555 2.02 LINK ND2 ASN A 18 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1